Nuveen Asset Management, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$15,040,231
-2.0%
181,799
+1.1%
0.00%
-20.0%
Q1 2024$15,351,649
-0.2%
179,867
+0.0%
0.01%0.0%
Q4 2023$15,375,211
-3.5%
179,806
+1.1%
0.01%
-16.7%
Q3 2023$15,924,905
+5.1%
177,773
-0.1%
0.01%
+20.0%
Q2 2023$15,151,259
+106396.5%
177,957
+3.5%
0.01%0.0%
Q1 2023$14,227
-7.2%
171,919
-11.8%
0.01%
-16.7%
Q4 2022$15,338
-99.9%
195,011
+1.9%
0.01%0.0%
Q3 2022$14,166,000
+17.5%
191,356
+3.4%
0.01%
+20.0%
Q2 2022$12,058,000
+13.8%
185,006
-2.9%
0.01%
+66.7%
Q1 2022$10,594,000
+4.9%
190,531
+0.1%
0.00%0.0%
Q4 2021$10,098,000
-33.9%
190,378
-12.0%
0.00%
-40.0%
Q3 2021$15,271,000
-9.7%
216,334
-14.8%
0.01%0.0%
Q2 2021$16,911,000
-18.7%
253,774
+35.4%
0.01%
-28.6%
Q1 2021$20,799,000
-14.5%
187,361
-8.5%
0.01%
-12.5%
Q4 2020$24,320,000
+92.5%
204,796
+41.4%
0.01%
+60.0%
Q3 2020$12,637,000
-11.5%
144,837
-9.2%
0.01%
-16.7%
Q2 2020$14,282,000
-70.5%
159,466
-67.2%
0.01%
-75.0%
Q1 2020$48,473,000
+31.2%
486,385
+51.2%
0.02%
+71.4%
Q4 2019$36,957,000
-19.9%
321,644
-12.1%
0.01%
-26.3%
Q3 2019$46,145,000
-8.8%
365,821
-13.0%
0.02%
-5.0%
Q2 2019$50,613,000
+3454.3%
420,579
+1144.0%
0.02%
+122.2%
Q4 2013$1,424,000
-46.6%
33,809
-49.4%
0.01%
-47.1%
Q3 2013$2,666,000
+8.6%
66,858
+12.6%
0.02%
+6.2%
Q2 2013$2,455,00059,3630.02%
Other shareholders
HAEMONETICS CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders